Home Compare MCO vs NOVN.SW
Stock Comparison · Comparison

Moody's vs Novartis: Which Stock Looks Stronger in 2026?

Moody's holds the cleaner structural position, with growth as the main driver and stability adding further support. Novartis still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, Novartis carries the stronger setup — intact trend against Moody's's broken trend. That leaves a split case: the structural lead stays with Moody's, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Growth still does most of the heavy lifting in this comparison. Moody's Corporation leads by 8 points on the overall comparison score.

Trajectory Similarity
0.65
Moderately similar
Peer-set rank: #19
within Moody's Corporation's functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

The pair shares a valid long-term profile match, but the trajectories are not especially close.

The strongest overlap appears in revenue growth trajectory and margin trend.

Similarity drivers
revenue growth trajectorymargin trend
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
MCO
Moody's Corporation
63
Peer-Score
Signal qualityHigh
vs
NOVN.SW
Novartis AG
55
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: MCO vs NOVN.SW Profitability 76 60 Stability 35 78 Valuation 53 55 Growth 84 22 MCO NOVN.SW
Gap Ranking
#1 Growth +62
#2 Stability +43
#3 Profitability +16
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for MCO and NOVN.SW Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer MCONOVN.SW Relative valuation Structural strength

Moody's Corporation is stronger, but the price setup still looks more supportive for Novartis AG.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, Moody's Corporation ranks near the top of the group; Novartis AG sits in the weaker half.
Stability
The same broad pattern appears on stability: Novartis AG ranks near the top of the group, while Moody's Corporation stays in the weaker half.
Growth — Dominant Gap
MCO
84
NOVN.SW
22
Gap+62in favour of MCO

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

Stability still leans toward Novartis AG, so the lead is real without reading as one-way.

What this means for the comparison

Growth settles the comparison, while pricing and stability keep the broader setup from looking fully aligned.

Explore full peer positioning in AssetNext

Break down the MCO vs NOVN.SW comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how MCO and NOVN.SW each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.